Abstract:Precise combination therapy, involving multiple chemotherapeutics with pharmacologically synergistic antitumor effects, is a promising approach to address the challenge of monotherapy with insufficient activity towards their targets of interest. We employed PtFpyridine coordination-driven assembly to construct a stoichiometric coordination complex of camptothecin and organoplatinum (II) (Pt-CPT). The Pt-CPT complex exhibited a remarkable synergistic effect toward several tumor cell lines, which is equal to the optimal synergistic effect of (PEt3)2Pt(OTf)2 (Pt) and CPT mixture at various ratios. An amphiphilic polymer with H2O2-responsiveness and glutathione (GSH)-depleting ability ( PO ) was used to encapsulate Pt-CPT complex to enable the nanomedicine (Pt-CPT@PO) with prolonged blood cir-culation and elevated tumor accumulation. The Pt-CPT@PO nanomedicine exhibited remarkable syn-ergistic antitumor efficacy and antimetastatic effect on a mice orthotopic breast tumor model. This work demonstrated the potential of stoichiometric coordination-driven assembly of organic therapeu-tics with metal-based drugs in developing advanced nanomedicine with optimal synergistic antitumor activity.Statement of significanceIn this study, for the first time, we employed PtFpyridine coordination-driven assembly to construct a stoichiometric coordination complex of camptothecin and organoplatinum (II) (Pt-CPT), with an optimal synergistic effect at various ratios. Then it was encapsulated into an amphiphilic polymer with H2O2-responsiveness and glutathione (GSH)-depleting ability ( PO ) to enable the nanomedicine (Pt-CPT@PO) with prolonged blood circulation and elevated tumor accumulation. The Pt-CPT@PO nanomedicine ex-hibited remarkable synergistic antitumor efficacy and antimetastatic effect on a mice orthotopic breast tumor model.(c) 2023 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Polyoxometalate-biomolecule Conjugates: a New Approach to Create Hybrid Drugs for Cancer Therapeutics.

MOF × Biopolymer: Collaborative Combination of Metal–Organic Framework and Biopolymer for Advanced Anticancer Therapy

Polyoxometalate-Based Organic-Inorganic Hybrids as Antitumor Drugs.

Supramolecular polymeric prodrug micelles for efficient anticancer drug delivery

Polymeric Prodrug by Supramolecular Polymerization

A Nanomedicine Based on Stoichiometric Coordination of Camptothecin and Organoplatinum (II) for Synergistic Antitumor Therapy.

Polyoxometalates Immobilized on MIL-100 (fe) As an Emerging Platform for Eliminating Breast Cancer Tumor Cells

Anticancer Polyoxometalates

Promising application of polyoxometalates in the treatment of cancer, infectious diseases and Alzheimer's disease

Promising Application of Polyoxometalates in the Treatment of Cancer, Infectious Diseases and Alzheimer’s Disease

Hetero-bimetallic Transition Metal-Substituted Krebs-type Polyoxometalate with N-chelating Ligand As Anticancer Agents

Polyoxometalates Nanoparticles Improve Anti-Tumor Activity by Maximal Cellular Uptake

Poly(l-Ornithine)-Based Polymeric Micelles as pH-Responsive Macromolecular Anticancer Agents

Combinatorial discovery of Mo-based polyoxometalate clusters for tumor photothermal therapy and normal cell protection

A Polymer–(Tandem Drugs) Conjugate for Enhanced Cancer Treatment

Ph-Responsive Polymer–drug Conjugates As Multifunctional Micelles for Cancer-Drug Delivery

Tris‐functionalized polyoxotungstovanadate‐mediated antitumor efficacy involves multiple cell death pathways

Progress in the Synthesis of Heteropolyoxometalate Clusters Andtheir Applications in Biological Treatment

Synergistic Therapy of a Naturally Inspired Glycopolymer‐Based Biomimetic Nanomedicine Harnessing Tumor Genomic Instability

Synthesis, Cytotoxicity and Antitumour Mechanism Investigations of Polyoxometalate Doped Silica Nanospheres on Breast Cancer MCF-7 Cells.

A polymer-(tandem drugs) conjugate for enhanced cancer treatment.